XOMA Royalty (XOMA) FCF Margin (2011 - 2026)

XOMA Royalty's (XOMA) quarterly FCF Margin came in at 49.69% in Q1 2026, down 526.0% year-on-year from 11.66% in Q1 2025, and up 487.51% quarter-over-quarter from 12.82% in Q4 2025.

XOMA Royalty (XOMA) FCF Margin (2011 - 2026) Analysis & Trends

XOMA Royalty has disclosed FCF Margin across 16 years of filings, most recently posting 49.69% for Q1 2026.

  • FCF Margin for Q1 2026 came in at 49.69%, down 526.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 11.24% (up 8041.0% YoY), and the FY2025 annual result was 5.51%, up 5384.0% from the prior year.
  • FCF Margin came in at 49.69% for Q1 2026 at XOMA Royalty, up from 12.82% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 128.76% in Q2 2025 to a low of 34500.0% in Q3 2024.
  • The 5-year median for FCF Margin is 252.89% (2023), against an average of 2321.07%.
  • Across the five-year window, FCF Margin tumbled 3424711 bps in 2024 and surged 3436844 bps in 2025, its largest moves.
  • XOMA Royalty's FCF Margin stood at 261.78% in 2022, then climbed by 18 bps to 214.24% in 2023, then tumbled by 171 bps to 581.2% in 2024, then jumped by 98 bps to 12.82% in 2025, then surged by 488 bps to 49.69% in 2026.
  • The last three FCF Margin figures came in at 49.69% (Q1 2026), 12.82% (Q4 2025), and 131.56% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -3.98%
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 43.35%
9 Abivax 95.45 Bn 95.45 Bn - -
10 XOMA Royalty 5.52 Mn -60.56 Mn - 49.69%

Historic Data

Download Data
DateValue
Mar 31, 2026 49.69%
Dec 31, 2025 -12.82%
Sep 30, 2025 -131.56%
Jun 30, 2025 128.76%
Mar 31, 2025 54.95%
Dec 31, 2024 -581.20%
Sep 30, 2024 -34,500.00%
Jun 30, 2024 54.27%
Mar 31, 2024 -333.15%
Dec 31, 2023 -214.24%
Sep 30, 2023 -252.89%
Jun 30, 2023 -1,047.67%
Mar 31, 2023 -1,126.77%
Dec 31, 2022 -261.78%
Sep 30, 2022 -812.20%
Jun 30, 2022 -439.17%
Mar 31, 2022 -32.48%
Dec 31, 2021 15,321.00%
Sep 30, 2021 -327.13%
Jun 30, 2021 -441.18%